We are monitoring the impact of COVID-19 on Gastroparesis Drugs Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 5069
Share on
Share on

Global Gastroparesis Drugs Market Size, Share, Trends and Growth Analysis Report – Segmented By Drug Class, Disease Type, End User and Region - Industry Forecast (2020 to 2025)

Pulished: February, 2020
ID: 5069
Pages: 145

Gastroparesis Drugs Market Size (2020 to 2025)

The Global Gastroparesis Drugs market size was around USD 5.22 billion in 2020. It is expected to grow at a CAGR of 4.8% to reach USD 6.6 billion by 2025.

Normal spontaneous movements of the muscles in the stomach are affected when a person is suffering from Gastroparesis often causing vomiting, improper digestion etc. Erythromycin, reglan are few drugs prescribed for the treatment.

Augmenting geriatric population, increased number of surgeries causing Gastroparesis as a side effect, growing number of people with diabetes, and introduction of new drugs in the market for controlling symptoms like nausea are the major factors driving the growth of this market. Negative side effects of prescribed drugs, inordinate delays in regulatory approvals, and complicated diagnostic procedure are the major factors inhibiting market growth.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Covered

By Type, Production Technologies and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

 

This research report on the global gastroparesis drugs market has been segmented and sub-segmented based on the type, production technologies and region.

Gastroparesis Drugs Market – By Drug Class

  • Prokinetic Agents 
  • Antiemetic Agents
  • Botulinum Toxin Injections     

Gastroparesis Drugs Market – By Disease Class

  • Diabetic Gastroparesis       
  • Idiopathic Gastroparesis    
  • Post-surgical Gastroparesis              
  • Others      

On the basis of disease class, the Idiopathic Gastroparesis segment performed a leading role in the market in 2019 and will retain its position till 2024. Its causes are unknown. However, this condition can be managed by dietary management.

Gastroparesis Drugs Market – By End User

  • Hospitals  
  • Pharmacies             
  • Clinics       
  • E-commerce      

Gastroparesis Drugs Market – By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Regionally, North America accounted for the largest share in the global gastroparesis drugs market in 2019. US is expected to lead the regional market in the forecast period. Europe is a close second by market share. UK captured largest market share in European market. Asia Pacific is the fastest growing market and is anticipated to remain so in the forecast period. Emerging economies of India and China are spearheading this growth spurt. Latin America and MEA are poised for a robust growth in the forecast period due to increased investments by major companies in the market.

NOTABLE COMPANIES IN THE MARKET

List of prominent companies dominating the Global Gastroparesis Drugs Market profiled in this report are Bayer HealthCare AG, Bioniche Animal Halth Canada, Sanofi Animal Health, Inc., Biogenesis Bago SA, Heska Corporation, Indian Immunologicals Ltd., Boehringer Ingelheim GmbH, Zoetis, Novartis Animal Health, Inc., Merck & Co. Inc. and Protein Sciences.

1. Introduction                                

               1.1 Market Definition                    

               1.2 Study Deliverables                  

               1.3 Base Currency, Base Year and Forecast Periods                          

               1.4 General Study Assumptions                 

2. Research Methodology                                          

               2.1 Introduction                             

               2.2 Research Phases                      

                              2.2.1 Secondary Research           

                              2.2.2 Primary Research 

                              2.2.3 Econometric Modelling      

                              2.2.4 Expert Validation  

               2.3 Analysis Design                        

               2.4 Study Timeline                         

3. Overview                                     

               3.1 Executive Summary                

               3.2 Key Inferences                         

               3.3 Epidemology                            

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

               4.1 Market Drivers                         

               4.2 Market Restraints                   

               4.3 Key Challenges                         

               4.4 Current Opportunities in the Market               

5. Market Segmentation                                            

               5.1 Drug Class                  

                              5.1.1 Introduction           

                              5.1.2 Prokinetic Agents 

                              5.1.3 Antiemetic Agents

                              5.1.4 Botulinum Toxin Injections              

                              5.1.5  Y-o-Y Growth Analysis, By Drug Class          

                              5.1.6  Market Attractiveness Analysis, By Drug Class        

                              5.1.7  Market Share Analysis, By Drug Class         

               5.2 Disease Type                            

                              5.2.1 Introduction           

                              5.2.2 Diabetic Gastroparesis       

                              5.2.3 Idiopathic Gastroparesis    

                              5.2.4 Post-surgical Gastroparesis              

                              5.2.5 Others      

                              5.2.6 Y-o-Y Growth Analysis, By Disease Type      

                              5.2.7 Market Attractiveness Analysis, By Disease Type    

                              5.2.8 Market Share Analysis, By Disease Type     

               5.3 End User                     

                              5.3.1 Introduction           

                              5.3.2 Hospitals  

                              5.3.3 Pharmacies             

                              5.3.4 Clinics       

                              5.3.5 E-commerce          

                              5.3.6 Y-o-Y Growth Analysis, By End User             

                              5.3.7 Market Attractiveness Analysis, By End User            

                              5.3.8 Market Share Analysis, By End User             

6. Geographical Analysis                                            

               6.1 Introduction                             

                              6.1.1 Regional Trends    

                              6.1.2 Impact Analysis     

                              6.1.3 Y-o-Y Growth Analysis        

                                             6.1.3.1 By Geographical Area

                                             6.1.3.2 By Drug Class

                                             6.1.3.3 By Disease Type

                                             6.1.3.4 By End User

                              6.1.4  Market Attractiveness Analysis      

                                             6.1.4.1 By Geographical Area

                                             6.1.4.2 By Drug Class

                                             6.1.4.3 By Disease Type

                                             6.1.4.4 By End User

                              6.1.5  Market Share Analysis       

                                             6.1.5.1 By Geographical Area

                                             6.1.5.2 By Drug Class

                                             6.1.5.3 By Disease Type

                                             6.1.5.4 By End User

               6.2 North America                         

                              6.1.1 Introduction           

                              6.1.2 United States         

                              6.1.3 Canada     

               6.3 Europe                        

                              6.2.1 Introduction           

                              6.2.2 U.K            

                              6.2.3 Spain         

                              6.2.4 Germany  

                              6.2.5 Italy           

                              6.2.6 France      

               6.4 Asia-Pacific                

                              6.3.1 Introduction           

                              6.3.2 China        

                              6.3.3 India         

                              6.3.4 Japan        

                              6.3.5 Australia   

                              6.3.6 South Korea           

               6.5 Latin America                           

                              6.4.1 Introduction           

                              6.4.2 Brazil         

                              6.4.3 Argentina 

                              6.4.4 Mexico     

                              6.4.5 Rest of Latin America          

               6.6 Middle East & Africa              

                              6.5.1 Introduction           

                              6.5.2 Middle-East           

                              6.5.3 Africa        

7. Strategic Analysis                                      

               7.1 PESTLE analysis                        

                              7.1.1 Political    

                              7.1.2 Economic 

                              7.1.3 Social        

                              7.1.4 Technological        

                              7.1.5 Legal         

                              7.1.6 Environmental       

               7.2 Porter’s Five analysis                             

                              7.2.1 Bargaining Power of Suppliers         

                              7.2.2 Bargaining Power of Consumers     

                              7.2.3 Threat of New Entrants      

                              7.2.4 Threat of Substitute Products and Services

                              7.2.5 Competitive Rivalry within the Industry      

8. Market Leaders' Analysis                                       

               8.1 Allergan, Plc.                            

                              8.1.1 Overview 

                              8.1.2 Product Analysis   

                              8.1.3 Financial analysis  

                              8.1.4 Recent Developments        

                              8.1.5 SWOT analysis       

                              8.1.6 Analyst View          

               8.2 Abbott Laboratories (Abbott Arzneimittel GmbH)                      

               8.3 AstraZeneca Plc.                      

               8.4 Cadila Pharmaceuticals Ltd.                

               8.5 ETX Pharma, Inc                      

               8.6 Evoke Pharma                          

               8.7 GlaxoSmithKline Plc.                             

               8.8 Neurogastrx, Inc.                    

               8.9 Valeant Pharmaceuticals International, Inc.                 

               8.10 Theravance Biopharma                      

9. Competitive Landscape                                         

               9.1 Market share analysis                           

               9.2 Merger and Acquisition Analysis                       

               9.3 Agreements, collaborations and Joint Ventures                          

               9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                          

               a) List of Tables                

               b) List of Figures                             

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Gastroparesis Drugs Market, By Region, From 2020 to 2025 (USD Billion)
  2. Global Gastroparesis Drugs Market, By Drug Class, From 2020 to 2025 (USD Billion)
  3. Global Prokinetic Agents Market, By Region, From 2020 to 2025 (USD Billion)
  4. Global Antiemetic Agents Market, By Region, From 2020 to 2025 (USD Billion)
  5. Global Botulinum Toxin Injections Market, By Region, From 2020 to 2025 (USD Billion)
  6. Global Gastroparesis Drugs Market, By Disease Type, From 2020 to 2025 (USD Billion)
  7. Global Diabetic Gastroparesis Market, By Region, From 2020 to 2025 (USD Billion)
  8. Global Idiopathic Gastroparesis Market, By Region, From 2020 to 2025 (USD Billion)
  9. Global Post-surgical Gastroparesis Market, By Region, From 2020 to 2025 (USD Billion)
  10. Global Others Market, By Region, From 2020 to 2025 (USD Billion)
  11. Global Gastroparesis Drugs Market, By End User, From 2020 to 2025 (USD Billion)
  12. Global Hospitals Market, By Region, From 2020 to 2025 (USD Billion)
  13. Global Pharmacies Market, By Region, From 2020 to 2025 (USD Billion)
  14. Global Clinics Market, By Region, From 2020 to 2025 (USD Billion)
  15. Global E-commerce Market, By Region, From 2020 to 2025 (USD Billion)
  16. North America Gastroparesis Drugs Market, By Drug Class, From 2020 to 2025 (USD Billion)
  17. North America Prokinetic Agents Market, By Region, From 2020 to 2025 (USD Billion)
  18. North America Antiemetic Agents Market, By Region, From 2020 to 2025 (USD Billion)
  19. North America Botulinum Toxin Injections Market, By Region, From 2020 to 2025 (USD Billion)
  20. North America Gastroparesis Drugs Market, By Disease Type, From 2020 to 2025 (USD Billion)
  21. North America Diabetic Gastroparesis Market, By Region, From 2020 to 2025 (USD Billion)
  22. North America Idiopathic Gastroparesis Market, By Region, From 2020 to 2025 (USD Billion)
  23. North America Post-surgical Gastroparesis Market, By Region, From 2020 to 2025 (USD Billion)
  24. North America Others Market, By Region, From 2020 to 2025 (USD Billion)
  25. North America Gastroparesis Drugs Market, By End User, From 2020 to 2025 (USD Billion)
  26. North America Hospitals Market, By Region, From 2020 to 2025 (USD Billion)
  27. North America Pharmacies Market, By Region, From 2020 to 2025 (USD Billion)
  28. North America Clinics Market, By Region, From 2020 to 2025 (USD Billion)
  29. North America E-commerce Market, By Region, From 2020 to 2025 (USD Billion)
  30. United States Gastroparesis Drugs Market, By Drug Class, From 2020 to 2025 (USD Billion)
  31. United States Gastroparesis Drugs Market, By Disease Type, From 2020 to 2025 (USD Billion)
  32. United States Gastroparesis Drugs Market, By End User, From 2020 to 2025 (USD Billion)
  33. Canada Gastroparesis Drugs Market, By Drug Class, From 2020 to 2025 (USD Billion)
  34. Canada Gastroparesis Drugs Market, By Disease Type, From 2020 to 2025 (USD Billion)
  35. Canada Gastroparesis Drugs Market, By End User, From 2020 to 2025 (USD Billion)
  36. Europe Gastroparesis Drugs Market, By Drug Class, From 2020 to 2025 (USD Billion)
  37. Europe Prokinetic Agents Market, By Region, From 2020 to 2025 (USD Billion)
  38. Europe Antiemetic Agents Market, By Region, From 2020 to 2025 (USD Billion)
  39. Europe Botulinum Toxin Injections Market, By Region, From 2020 to 2025 (USD Billion)
  40. Europe Gastroparesis Drugs Market, By Disease Type, From 2020 to 2025 (USD Billion)
  41. Europe Diabetic Gastroparesis Market, By Region, From 2020 to 2025 (USD Billion)
  42. Europe Idiopathic Gastroparesis Market, By Region, From 2020 to 2025 (USD Billion)
  43. Europe Post-surgical Gastroparesis Market, By Region, From 2020 to 2025 (USD Billion)
  44. Europe Others Market, By Region, From 2020 to 2025 (USD Billion)
  45. Europe Gastroparesis Drugs Market, By End User, From 2020 to 2025 (USD Billion)
  46. Europe Hospitals Market, By Region, From 2020 to 2025 (USD Billion)
  47. Europe Pharmacies Market, By Region, From 2020 to 2025 (USD Billion)
  48. Europe Clinics Market, By Region, From 2020 to 2025 (USD Billion)
  49. Europe E-commerce Market, By Region, From 2020 to 2025 (USD Billion)
  50. U.K. Gastroparesis Drugs Market, By Drug Class, From 2020 to 2025 (USD Billion)
  51. U.K. Gastroparesis Drugs Market, By Disease Type, From 2020 to 2025 (USD Billion)
  52. U.K. Gastroparesis Drugs Market, By End User, From 2020 to 2025 (USD Billion)
  53. Germany Gastroparesis Drugs Market, By Drug Class, From 2020 to 2025 (USD Billion)
  54. Germany Gastroparesis Drugs Market, By Disease Type, From 2020 to 2025 (USD Billion)
  55. Germany Gastroparesis Drugs Market, By End User, From 2020 to 2025 (USD Billion)
  56. France Gastroparesis Drugs Market, By Drug Class, From 2020 to 2025 (USD Billion)
  57. France Gastroparesis Drugs Market, By Disease Type, From 2020 to 2025 (USD Billion)
  58. France Gastroparesis Drugs Market, By End User, From 2020 to 2025 (USD Billion)
  59. Italy Gastroparesis Drugs Market, By Drug Class, From 2020 to 2025 (USD Billion)
  60. Italy Gastroparesis Drugs Market, By Disease Type, From 2020 to 2025 (USD Billion)
  61. Italy Gastroparesis Drugs Market, By End User, From 2020 to 2025 (USD Billion)
  62. Spain Gastroparesis Drugs Market, By Drug Class, From 2020 to 2025 (USD Billion)
  63. Spain Gastroparesis Drugs Market, By Disease Type, From 2020 to 2025 (USD Billion)
  64. Spain Gastroparesis Drugs Market, By End User, From 2020 to 2025 (USD Billion)
  65. Asia Pacific Gastroparesis Drugs Market, By Drug Class, From 2020 to 2025 (USD Billion)
  66. Asia Pacific Prokinetic Agents Market, By Region, From 2020 to 2025 (USD Billion)
  67. Asia Pacific Antiemetic Agents Market, By Region, From 2020 to 2025 (USD Billion)
  68. Asia Pacific Botulinum Toxin Injections Market, By Region, From 2020 to 2025 (USD Billion)
  69. Asia Pacific Gastroparesis Drugs Market, By Disease Type, From 2020 to 2025 (USD Billion)
  70. Asia Pacific Diabetic Gastroparesis Market, By Region, From 2020 to 2025 (USD Billion)
  71. Asia Pacific Idiopathic Gastroparesis Market, By Region, From 2020 to 2025 (USD Billion)
  72. Asia Pacific Post-surgical Gastroparesis Market, By Region, From 2020 to 2025 (USD Billion)
  73. Asia Pacific Others Market, By Region, From 2020 to 2025 (USD Billion)
  74. Asia Pacific Gastroparesis Drugs Market, By End User, From 2020 to 2025 (USD Billion)
  75. Asia Pacific Hospitals Market, By Region, From 2020 to 2025 (USD Billion)
  76. Asia Pacific Pharmacies Market, By Region, From 2020 to 2025 (USD Billion)
  77. Asia Pacific Clinics Market, By Region, From 2020 to 2025 (USD Billion)
  78. Asia Pacific E-commerce Market, By Region, From 2020 to 2025 (USD Billion)
  79. Japan Gastroparesis Drugs Market, By Drug Class, From 2020 to 2025 (USD Billion)
  80. Japan Gastroparesis Drugs Market, By Disease Type, From 2020 to 2025 (USD Billion)
  81. Japan Gastroparesis Drugs Market, By End User, From 2020 to 2025 (USD Billion)
  82. China Gastroparesis Drugs Market, By Drug Class, From 2020 to 2025 (USD Billion)
  83. China Gastroparesis Drugs Market, By Disease Type, From 2020 to 2025 (USD Billion)
  84. China Gastroparesis Drugs Market, By End User, From 2020 to 2025 (USD Billion)
  85. India Gastroparesis Drugs Market, By Drug Class, From 2020 to 2025 (USD Billion)
  86. India Gastroparesis Drugs Market, By Disease Type, From 2020 to 2025 (USD Billion)
  87. India Gastroparesis Drugs Market, By End User, From 2020 to 2025 (USD Billion)
  88. Australia Gastroparesis Drugs Market, By Drug Class, From 2020 to 2025 (USD Billion)
  89. Australia Gastroparesis Drugs Market, By Disease Type, From 2020 to 2025 (USD Billion)
  90. Australia Gastroparesis Drugs Market, By End User, From 2020 to 2025 (USD Billion)
  91. South Korea Gastroparesis Drugs Market, By Drug Class, From 2020 to 2025 (USD Billion)
  92. South Korea Gastroparesis Drugs Market, By Disease Type, From 2020 to 2025 (USD Billion)
  93. South Korea Gastroparesis Drugs Market, By End User, From 2020 to 2025 (USD Billion)
  94. Latin America Gastroparesis Drugs Market, By Drug Class, From 2020 to 2025 (USD Billion)
  95. Latin America Prokinetic Agents Market, By Region, From 2020 to 2025 (USD Billion)
  96. Latin America Antiemetic Agents Market, By Region, From 2020 to 2025 (USD Billion)
  97. Latin America Botulinum Toxin Injections Market, By Region, From 2020 to 2025 (USD Billion)
  98. Latin America Gastroparesis Drugs Market, By Disease Type, From 2020 to 2025 (USD Billion)
  99. Latin America Diabetic Gastroparesis Market, By Region, From 2020 to 2025 (USD Billion)
  100. Latin America Idiopathic Gastroparesis Market, By Region, From 2020 to 2025 (USD Billion)
  101. Latin America Post-surgical Gastroparesis Market, By Region, From 2020 to 2025 (USD Billion)
  102. Latin America Others Market, By Region, From 2020 to 2025 (USD Billion)
  103. Latin America Gastroparesis Drugs Market, By End User, From 2020 to 2025 (USD Billion)
  104. Latin America Hospitals Market, By Region, From 2020 to 2025 (USD Billion)
  105. Latin America Pharmacies Market, By Region, From 2020 to 2025 (USD Billion)
  106. Latin America Clinics Market, By Region, From 2020 to 2025 (USD Billion)
  107. Latin America E-commerce Market, By Region, From 2020 to 2025 (USD Billion)
  108. Brazil Gastroparesis Drugs Market, By Drug Class, From 2020 to 2025 (USD Billion)
  109. Brazil Gastroparesis Drugs Market, By Disease Type, From 2020 to 2025 (USD Billion)
  110. Brazil Gastroparesis Drugs Market, By End User, From 2020 to 2025 (USD Billion)
  111. Argentina Gastroparesis Drugs Market, By Drug Class, From 2020 to 2025 (USD Billion)
  112. Argentina Gastroparesis Drugs Market, By Disease Type, From 2020 to 2025 (USD Billion)
  113. Argentina Gastroparesis Drugs Market, By End User, From 2020 to 2025 (USD Billion)
  114. Mexico Gastroparesis Drugs Market, By Drug Class, From 2020 to 2025 (USD Billion)
  115. Mexico Gastroparesis Drugs Market, By Disease Type, From 2020 to 2025 (USD Billion)
  116. Mexico Gastroparesis Drugs Market, By End User, From 2020 to 2025 (USD Billion)
  117. Rest of Latin America Gastroparesis Drugs Market, By Drug Class, From 2020 to 2025 (USD Billion)
  118. Rest of Latin America Gastroparesis Drugs Market, By Disease Type, From 2020 to 2025 (USD Billion)
  119. Rest of Latin America Gastroparesis Drugs Market, By End User, From 2020 to 2025 (USD Billion)
  120. Middle East and Africa Gastroparesis Drugs Market, By Drug Class, From 2020 to 2025 (USD Billion)
  121. Middle East and Africa Prokinetic Agents Market, By Region, From 2020 to 2025 (USD Billion)
  122. Middle East and Africa Antiemetic Agents Market, By Region, From 2020 to 2025 (USD Billion)
  123. Middle East and Africa Botulinum Toxin Injections Market, By Region, From 2020 to 2025 (USD Billion)
  124. Middle East and Africa Gastroparesis Drugs Market, By Disease Type, From 2020 to 2025 (USD Billion)
  125. Middle East and Africa Diabetic Gastroparesis Market, By Region, From 2020 to 2025 (USD Billion)
  126. Middle East and Africa Idiopathic Gastroparesis Market, By Region, From 2020 to 2025 (USD Billion)
  127. Middle East and Africa Post-surgical Gastroparesis Market, By Region, From 2020 to 2025 (USD Billion)
  128. Middle East and Africa Others Market, By Region, From 2020 to 2025 (USD Billion)
  129. Middle East and Africa Gastroparesis Drugs Market, By End User, From 2020 to 2025 (USD Billion)
  130. Middle East and Africa Hospitals Market, By Region, From 2020 to 2025 (USD Billion)
  131. Middle East and Africa Pharmacies Market, By Region, From 2020 to 2025 (USD Billion)
  132. Middle East and Africa Clinics Market, By Region, From 2020 to 2025 (USD Billion)
  133. Middle East and Africa E-commerce Market, By Region, From 2020 to 2025 (USD Billion)
  134. Middle East Gastroparesis Drugs Market, By Drug Class, From 2020 to 2025 (USD Billion)
  135. Middle East Gastroparesis Drugs Market, By Disease Type, From 2020 to 2025 (USD Billion)
  136. Middle East Gastroparesis Drugs Market, By End User, From 2020 to 2025 (USD Billion)
  137. Africa Gastroparesis Drugs Market, By Drug Class, From 2020 to 2025 (USD Billion)
  138. Africa Gastroparesis Drugs Market, By Disease Type, From 2020 to 2025 (USD Billion)
  139. Africa Gastroparesis Drugs Market, By End User, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample